Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Administration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04756401
What this trial is testing

Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Academic and Community Cancer Research United 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07828522
What this trial is testing

F182112 in Combination With Isatuximab and Lenalidomide for the Treatment of Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Transplant-eligible Patients
Institute of Hematology & Blood Diseases Hospital, China 10
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Not applicableUnknownNCT03082430
What this trial is testing

GO PRP: Assessing the Efficacy of Intra Articular Injection of Platelets Rich Plasma for Gonarthrosis Treatment in Routine Care

Who this might be right for
Knee Osteoarthritis
Hospital St. Joseph, Marseille, France 60
Not applicableLooking for participantsNCT06151730
What this trial is testing

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

Who this might be right for
Chronic Lymphocytic LeukemiaHematopoietic and Lymphoid System NeoplasmMantle Cell Lymphoma+2 more
Mayo Clinic 100
Early research (Phase 1)UnknownNCT05325801
What this trial is testing

CAR-T Cells Targeting Both BCMA and GPRC5D in Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Zhejiang University 9
Testing effectiveness (Phase 2)Study completedNCT00884312
What this trial is testing

Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols

Who this might be right for
Multiple MyelomaSolid Tumors
Amgen 101
Not applicableStudy completedNCT03070028
What this trial is testing

Minimally Invasive Treatment Methods for Pilonidal Disease

Who this might be right for
Pilonidal Sinus
Uşak University 200
Not applicableLooking for participantsNCT07714811
What this trial is testing

Hyaluronic Acid Versus Platelet-Rich Plasma for Chronic Tendinopathy and Enthesopathy

Who this might be right for
TendinopathyEnthesopathyAchilles Tendinopathy+2 more
Ortonika Orthopedic Medical Clinic in Lublin 80
Not applicableUnknownNCT05378971
What this trial is testing

Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma

Who this might be right for
Multiple Myeloma
LanZhou University 15
Large-scale testing (Phase 3)Study completedNCT02211521
What this trial is testing

Comparison of Autologous Platelet-rich Plasma With Hyaluronic Acid for the Treatment of Osteoarthritis of the Knee Joint

Who this might be right for
Osteoarthritis, Knee
Samsung Medical Center 110
Not applicableUnknownNCT02233933
What this trial is testing

Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis

Who this might be right for
Rectal Bleeding
British Columbia Cancer Agency 20
Early research (Phase 1)Looking for participantsNCT05363111
What this trial is testing

Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
City of Hope Medical Center 15
Post-approval studies (Phase 4)Study completedNCT03453684
What this trial is testing

Pharmacokinetics of Preoperative Vancomycin

Who this might be right for
Surgical Site InfectionVancomycin
University of Colorado, Denver 60
Not applicableUnknownNCT06244121
What this trial is testing

Effect of Pyridoxine as Add-on Therapy in OCD Patients

Who this might be right for
OCD
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 76
Testing effectiveness (Phase 2)Ended earlyNCT00872300
What this trial is testing

PHA-739358 for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nerviano Medical Sciences 7
Testing effectiveness (Phase 2)Study completedNCT04374565
What this trial is testing

Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia

Who this might be right for
Corona Virus InfectionSARS-CoV 2SARS Pneumonia+1 more
University of Virginia 29
Testing effectiveness (Phase 2)Study completedNCT04468009
What this trial is testing

Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma

Who this might be right for
SARS-Associated CoronavirusCovid19SARS-CoV Infection
Hospital de Infecciosas Francisco Javier Muniz 134
Testing effectiveness (Phase 2)Looking for participantsNCT04268199
What this trial is testing

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

Who this might be right for
MyelomaMyeloma Multiple
AHS Cancer Control Alberta 100
Early research (Phase 1)Study completedNCT01497093
What this trial is testing

Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 34
Next Page